IP Library › Granted Patent US 11,717,543
Granted Patent B2
US 11,717,543 · App. 16/907,381 · Granted Aug 8, 2023

Patent

Inventors: Philippe Langella (Velizy-Villacoublay, FR); Sylvie Miquel (Beaumont, FR); Rebeca Martin Rosique (Jouy en Josas, FR); Luis Bermudez Humaran (Jouy en Josas, FR); Muriel Thomas (Igny, FR); Harry Sokol (Paris, FR); Frédéric Carvalho (Clermont-Ferrand, FR); Vassilia Theodorou (Portet Sure Garonne, FR)
Assignees: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS; ECOLE D'INGENIEURS DE PURPAN
A61K35/741A23L33/135A61P29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,717,543
App. No.
16/907,381
Granted
Aug 8, 2023
Kind
B2
Abstract

The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.

Claims (5)

1. Method for the treatment of visceral abdominal pain in an individual, comprising administering to said individual a bacterial strain of the Faecalibacteriunm prausnitzii species, the bacterial strain being the strain deposited to the CNCM under the accession number I-4573.

2. The method according to claim 1 , wherein the visceral abdominal pain is a gastrointestinal pain.

3. The method according to claim 1 , wherein the visceral abdominal pain is caused by a gastrointestinal disorder.

4. The method according to claim 3 , wherein the gastrointestinal disorder is a gastrointestinal hypersensitivity.

5. The method according to claim 1 , wherein the bacterial strain is comprised in a composition comprising a physiologically acceptable medium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: LANGELLA, PHILIPPE; MIQUEL, SYLVIE; MARTIN ROSIQUE, REBECA; BERMUDEZ HUMARAN, LUIS; THOMAS, MURIEL; SOKOL, HARRY; CARVALHO, FREDERIC; THEODOROU, VASSILIA
To: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6); ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (APHP); ECOLE D'INGENIEURS DE PURPAN
Reel/Frame 052996/0809 →